Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 27;9(1):e16332.
doi: 10.2196/16332.

Prospective Evaluation of HIV Testing Technologies in a Clinical Setting: Protocol for Project DETECT

Joanne D Stekler  1   2   3 , Lauren R Violette  1 , Hollie A Clark  4 , Sarah J McDougal  1 , Lisa A Niemann  1 , David A Katz  3   5 , Pollyanna R Chavez  4 , Laura G Wesolowski  4 , Steven F Ethridge  4 , Vanessa M McMahan  1 , Andy Cornelius-Hudson  1 , Kevin P Delaney  4
Affiliations

Prospective Evaluation of HIV Testing Technologies in a Clinical Setting: Protocol for Project DETECT

Joanne D Stekler et al. JMIR Res Protoc. .

Abstract

Background: HIV testing guidelines provided by the Centers for Disease Control and Prevention (CDC) are continually changing to reflect advancements in new testing technology. Evaluation of existing and new point-of-care (POC) HIV tests is crucial to inform testing guidelines and provide information to clinicians and other HIV test providers. Characterizing the performance of POC HIV tests using unprocessed specimens can provide estimates for the window period of detection, or the time from HIV acquisition to test positivity, which allows clinicians and other HIV providers to select the appropriate POC HIV tests for persons who may be recently infected with HIV.

Objective: This paper describes the protocols and procedures used to evaluate the performance of the newest POC tests and determine their sensitivity during early HIV infection.

Methods: Project DETECT is a CDC-funded study that is evaluating POC HIV test performance. Part 1 is a cross-sectional, retrospective study comparing behavioral characteristics and HIV prevalence of the overall population of the Public Health-Seattle & King County (PHSKC) Sexually Transmitted Disease (STD) Clinic to Project DETECT participants enrolled in part 2. Part 2 is a cross-sectional, prospective study evaluating POC HIV tests in real time using unprocessed whole blood and oral fluid specimens. A POC nucleic acid test (NAT) was added to the panel of HIV tests in June 2018. Part 3 is a longitudinal, prospective study evaluating seroconversion sensitivity of POC HIV tests through serial follow-up testing. For comparison, HIV-1 RNA and HIV-1/HIV-2 antigen/antibody tests are also performed for participants enrolled in part 2 or 3. A behavioral survey that collects information about demographics, history of HIV testing, STD history, symptoms of acute HIV infection, substance use, sexual behaviors in the aggregate and with recent partners, and use of pre-exposure prophylaxis and antiretroviral therapy is completed at each part 2 or 3 visit.

Results: Between September 2015 and March 2019, there were 14,990 Project DETECT-eligible visits (part 1) to the PHSKC STD Clinic resulting in 1819 part 2 Project DETECT study visits. The longitudinal study within Project DETECT (part 3) enrolled 27 participants with discordant POC test results from their part 2 visit, and 10 (37%) were followed until they had fully seroconverted with concordant positive POC test results. Behavioral survey data and HIV test results, sensitivity, and specificity will be presented elsewhere.

Conclusions: Studies such as Project DETECT are critical for evaluating POC HIV test devices as well as describing characteristics of persons at risk for HIV acquisition in the United States. HIV tests in development, including POC NATs, will provide new opportunities for HIV testing programs.

International registered report identifier (irrid): RR1-10.2196/16332.

Keywords: HIV testing; acute HIV infection; nucleic acid tests; point-of-care tests.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Project DETECT study design.
Figure 2
Figure 2
Project DETECT part 3 procedures. Ag/Ab: antigen/antibody; NAT: nucleic acid test; DBS: dries blood spot.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Delaney KP, Wesolowski LG, Owen SM. The evolution of HIV testing continues. Sex Transm Dis. 2017 Dec;44(12):747–749. doi: 10.1097/OLQ.0000000000000736. - DOI - PubMed
    1. Pilcher CD, Tien HC, Eron JJ, Vernazza PL, Leu S, Stewart PW, Goh L, Cohen MS, Quest Study. Duke-UNC-Emory Acute HIV Consortium Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis. 2004 May 15;189(10):1785–1792. doi: 10.1086/386333. - DOI - PubMed
    1. Centers for Disease Control and Prevention Detection of acute HIV infection in two evaluations of a new HIV diagnostic testing algorithm—United States, 2011-2013. MMWR Morb Mortal Wkly Rep. 2013 Jun 21;62(24):489–494. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6224a2.htm - PMC - PubMed
    1. White DAE, Giordano TP, Pasalar S, Jacobson KR, Glick NR, Sha BE, Mammen PE, Hunt BR, Todorovic T, Moreno-Walton L, Adomolga V, Feaster DJ, Branson BM. Acute HIV discovered during routine HIV screening with HIV antigen-antibody combination tests in 9 US emergency departments. Ann Emerg Med. 2018 Jul;72(1):29–40. doi: 10.1016/j.annemergmed.2017.11.027. - DOI - PubMed
    1. Peters PJ, Westheimer E, Cohen S, Hightow-Weidman LB, Moss N, Tsoi B, Hall L, Fann C, Daskalakis DC, Beagle S, Patel P, Radix A, Foust E, Kohn RP, Marmorino J, Pandori M, Fu J, Samandari T, Gay CL. Screening yield of HIV antigen/antibody combination and pooled HIV RNA testing for acute HIV infection in a high-prevalence population. JAMA. 2016 Feb 16;315(7):682–690. doi: 10.1001/jama.2016.0286. - DOI - PubMed